Tamsulosin for Urinary Retention in Hospitalized Older Women

NCT01747993 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

34

Enrollment

OTHER

Sponsor class

Stopped low inclusion

Conditions

Urinary Retention

Interventions

DRUG: Tamsulosin (0.4 mg/j)
DRUG: Placebo

Sponsor

Assistance Publique - Hôpitaux de Paris